A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial NCT00810147 · COMPLETED
Trial details
- NCT number
- NCT00810147
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-06-01
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.